Username Password
S&P 500: 1,913.85
Change: -2.96%

GLAXOSMITHKLINE PLC (GSK)

Overview
Price 39.47
Price Change Today -$1.46 (-3.57%)
P&P rating Rating: 4
Open Price $39.95
Previous Close $40.93
Daily Range $39.35 - $40.03
52-Week Range $39.27 - $49.08
Volume 4
chart
Top Buy Analysis
BUY: GSK Rating: 4
Company: GLAXOSMITHKLINE PLC
Points: -57.72
Start Price: $33.46
Start Date: 05/28/2010 9:55 AM
adviceguy
adviceguy
P&P Score: 27.16
Recs:
#1 Quality
#2 Price

Comments: 0 | Comment

Top Sell Analysis
No Sell Analysis. Be the First.
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

52 Buy
0 Sell
 
Try it Free!
Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.95 11/06/10 Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) latest holdings as of the close on June 30, 2010 4 11/15/10
AndrewGreenBull
95.39 02/03/10 XNPT—Volatility or Opportunity? 0
AndrewGreenBull
95.39 01/20/10 FDA Calendar Focus: XNPT 0
Zacks_Analysts
0.00 06/04/13 Glaxo/Renaissance Ink Deal - Analyst Blog 0
Zacks_Analysts
0.00 02/13/13 Theravance Narrows Y/Y Loss - Analyst Blog 0
Zacks_Analysts
0.00 02/13/13 Theravance Narrows Y/Y Loss - Analyst Blog 0
Zacks_Analysts
0.00 02/12/13 Bayer Seeks Riociguat Approval - Analyst Blog 0
Zacks_Analysts
0.00 02/12/13 Bayer Seeks Riociguat Approval - Analyst Blog 0
Zacks_Analysts
0.00 02/12/13 Life's Products Gain FDA Approval - Analyst Blog 0
Zacks_Analysts
0.00 02/12/13 Life's Products Gain FDA Approval - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   ...  66  >>
Commentary
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -6.49
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -15.70
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -15.84
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -6.49
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -15.70
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -15.84
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $33.46
Points: -57.72
Created: 05/28/2010
#1 Quality
#2 Price

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $33.46
Points: -75.26
Created: 05/28/2010
#1 Quality
#2 Price

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $33.46
Points: -75.53
Created: 05/28/2010
#1 Quality
#2 Price

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $33.46
Points: -57.72
Created: 05/28/2010
#1 Quality
#2 Price

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3   4   5   6  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
olautern 1.31 BUY Week to a Month 12/05/2014 $46.04 $39.47
(-3.57%)
-14.27% -7.78% -6.49 view
olautern 1.31 BUY Week to a Month 12/05/2014 $46.04 $39.47
(-3.57%)
-14.27% +1.43% -15.70 view
olautern 1.31 BUY Week to a Month 12/05/2014 $46.04 $39.47
(-3.57%)
-14.27% +1.57% -15.84 view
olautern 1.31 BUY Week to a Month 12/05/2014 $46.04 $39.47
(-3.57%)
-14.27% -7.78% -6.49 view
olautern 1.31 BUY Week to a Month 12/05/2014 $46.04 $39.47
(-3.57%)
-14.27% +1.43% -15.70 view
olautern 1.31 BUY Week to a Month 12/05/2014 $46.04 $39.47
(-3.57%)
-14.27% +1.57% -15.84 view
vip 52.81 BUY One to Three Months 02/16/2012 $44.98 $39.47
(-3.57%)
-12.25% +40.93% -53.18
vip 52.81 BUY One to Three Months 02/16/2012 $44.98 $39.47
(-3.57%)
-12.25% +55.00% -67.25
vip 52.81 BUY One to Three Months 02/16/2012 $44.98 $39.47
(-3.57%)
-12.25% +55.22% -67.47
vip 52.81 BUY One to Three Months 02/16/2012 $44.98 $39.47
(-3.57%)
-12.25% +40.93% -53.18
Pages: [ 1 ]  2   3   4   5   6  >>
Sponsored Links